• ABOUT US
    ▼
    • Our Vision
    • Leadership Team
  • OUR RESEARCH
    ▼
    • Our Approach
    • Publications
    • Conferences
  • PROGRAMS
    ▼
    • Pipeline
    • VIS649 Sibeprenlimab
    • VIS171
    • VIS513
  • FOR PATIENTS
    ▼
    • Clinical Trials
    • IgA Nephropathy
  • CAREERS
    ▼
    • Open Positions & Benefits
    • Our Culture
    • Co-op program
  • Contact

Visterra

We Bring Better Biologics to Life

  • ABOUT US
    • Our Vision
    • Leadership Team
  • OUR RESEARCH
    • Our Approach
    • Publications
    • Conferences
  • PROGRAMS
    • Pipeline
    • VIS649 Sibeprenlimab
    • VIS171
    • VIS513
  • FOR PATIENTS
    • Clinical Trials
    • IgA Nephropathy
  • CAREERS
    • Open Positions & Benefits
    • Our Culture
    • Co-op program
  • Contact

Publications

Publications

Featured publications

Multi-omic single cell sequencing: Overview and opportunities for kidney disease therapeutic development

April 5, 2023 | Frontiers in Molecular Biosciences
Steven Pregizer, et. al.

Multi-omic single cell sequencing: Overview and opportunities for kidney disease therapeutic development

Steven Pregizer, Thom Vreven, Mohit Mathur, Luke Robinson

>READ

Quantifying the nativeness of antibody sequences using long short-term memory networks

December 31, 2019 | Protein Engineering, Design, and Selection
Andrew M Wollacott et al.

Quantifying the nativeness of antibody sequences using long short-term memory networks

Andrew M Wollacott, Chonghua Xue, Qiuyuan Qin, June Hua, Tanggis Bohnuud, Karthik Viswanathan, Vijaya B Kolachalama

>READ

A Proliferation Inducing Ligand (APRIL) targeted antibody is a safe and effective treatment of murine IgA nephropathy

March 16, 2019 | Kidney International
James R Myette et al.

A Proliferation Inducing Ligand (APRIL) targeted antibody is a safe and effective treatment of murine IgA nephropathy

James R Myette, Toshiki Kano, Hitoshi Suzuki, Susan E Sloan, Kristy J Szretter, Boopathy Ramakrishnan, Hedy Adari, Ketan D Deotale, Frank Engler, Zachary Shriver, Andrew M Wollacott, Yusuke Suzuki, Brian J G Pereira

>READ

Glycosylation at Asn91 of H1N1 haemagglutinin affects binding to glycan receptors.

December 19, 2011 | Scientific Reports
Venkataramanan Soundararajan et al.

Glycosylation at Asn91 of H1N1 haemagglutinin affects binding to glycan receptors.

Venkataramanan Soundararajan, Shu Zheng, Neel Patel, Ken Warnock, Rahul Raman, Ian A Wilson, S Raguram, V Sasisekharan, Ram Sasisekharan

>READ

Glycomics-based analysis of chicken red blood cells provides insight into the selectivity of the viral agglutination assay.

April 20, 2011 | The FEBS Journal
Udayanath Aich et al.

Glycomics-based analysis of chicken red blood cells provides insight into the selectivity of the viral agglutination assay.

Udayanath Aich, Nia Beckley, Zachary Shriver, Rahul Raman, Karthik Viswanathan, Sven Hobbie, Ram Sasisekharan

>READ

A single base-pair change in 2009 H1N1 hemagglutinin increases human receptor affinity and leads to efficient airborne viral transmission in ferrets.

March 2, 2011 | PLoS One
Karthik Viswanathan et al.

A single base-pair change in 2009 H1N1 hemagglutinin increases human receptor affinity and leads to efficient airborne viral transmission in ferrets.

Karthik Viswanathan, Xiaoying Koh, Aarthi Chandrasekaran, Claudia Pappas, Rahul Raman, Aravind Srinivasan, Zachary Shriver, Terrence M Tumpey, Ram Sasisekharan

>READ

Determinants of glycan receptor specificity of H2N2 influenza A virus hemagglutinin.

October 29, 2010 | PLoS One
Karthik Viswanathan et al.

Determinants of glycan receptor specificity of H2N2 influenza A virus hemagglutinin.

Karthik Viswanathan, Aarthi Chandrasekaran, Aravind Srinivasan, Rahul Raman, V Sasisekharan, Ram Sasisekharan

>READ

Glycans as receptors for influenza pathogenesis.

August 24, 2010 | Glycoconjugate Journal
Karthik Viswanathan et al.

Glycans as receptors for influenza pathogenesis.

Karthik Viswanathan, Aarthi Chandrasekaran, Aravind Srinivasan, Rahul Raman, V Sasisekharan, Ram Sasisekharan

>READ

Receptor specificity and transmission of H2N2 subtype viruses isolated from the pandemic of 1957.

June 21, 2010 | PLoS One
Claudia Pappas et al.

Receptor specificity and transmission of H2N2 subtype viruses isolated from the pandemic of 1957.

Claudia Pappas, Karthik Viswanathan, Aarthi Chandrasekaran, Rahul Raman, Jacqueline M Katz, Ram Sasisekharan, Terrence M Tumpey

>READ

Hemagglutinin receptor binding avidity drives influenza A virus antigenic drift.

October 30, 2009 | Science (New York, N.Y.)
Scott E Hensley et al.

Hemagglutinin receptor binding avidity drives influenza A virus antigenic drift.

Scott E Hensley, Suman R Das, Adam L Bailey, Loren M Schmidt, Heather D Hickman, Akila Jayaraman, Karthik Viswanathan, Rahul Raman, Ram Sasisekharan, Jack R Bennink, Jonathan W Yewdell

>READ

Context-specific target definition in influenza a virus hemagglutinin-glycan receptor interactions.

August 28, 2009 | Chemistry and Biology
Zachary Shriver et al.

Context-specific target definition in influenza a virus hemagglutinin-glycan receptor interactions.

Zachary Shriver, Rahul Raman, Karthik Viswanathan, Ram Sasisekharan

>READ

Transmission and pathogenesis of swine-origin 2009 A(H1N1) influenza viruses in ferrets and mice.

July 5, 2009 | Science (New York, N.Y.)
Taronna R Maines et al.

Transmission and pathogenesis of swine-origin 2009 A(H1N1) influenza viruses in ferrets and mice.

Taronna R Maines, Akila Jayaraman, Jessica A Belser, Debra A Wadford, Claudia Pappas, Hui Zeng, Kortney M Gustin, Melissa B Pearce, Karthik Viswanathan, Zachary H Shriver, Rahul Raman, Nancy J Cox, Ram Sasisekharan, Jacqueline M Katz, Terrence M Tumpey

>READ

Extrapolating from sequence–the 2009 H1N1 ‘swine’ influenza virus.

June 1, 2009 | Nature Biotechnology
Venkataramanan Soundararajan et al.

Extrapolating from sequence–the 2009 H1N1 ‘swine’ influenza virus.

Venkataramanan Soundararajan, Kannan Tharakaraman, Rahul Raman, S Raguram, Zachary Shriver, V Sasisekharan, Ram Sasisekharan

>READ
  • « Previous Page
  • 1
  • 2
  • 3
  • 4
  • 5
  • Next Page »

© 2023 Visterra, Inc. Terms of usePrivacy PolicySite Design: Fassino/Design